@article{article, title  = {{Bleeding risk with AZD6140, a reversible P2Y(12) receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial}},

 url = {{}},

 year = {{2009}},

 month = {{4}},

 author = {{Husted S and Harrington RA and Cannon CP and Storey RF and Mitchell P and Emanuelsson H}},

 doi = {{10.1111/j.1742-1241.2009.02030.x}},

 volume = {{63}},

 journal = {{INT J CLIN PRACT}},

 issue = {{4}},

 pages = {{667-670}},

 note = {{Accessed on 2024/12/22}}}